Treatment of Chronic Hepatitis C: Efficacy, Side Effects and Complications
Visceral Medicine · 2019 · 35 (3) · 161-170
DOI: 10.1159/000500963 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Visceral Medicine, online erschienen am 21.05.2019. Verfasst von Lisa Sandmann und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Gastroenterology, Hepatology and Endocrinology, Hannover Medical School, Hannover, Germany. Die Arbeit wurde bisher 71-mal zitiert (Crossref) und nennt 53 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
Background: Chronic hepatitis C virus (HCV) infection can lead to liver cirrhosis and its complications. Viral eradication is essential to prevent disease progression and reduces liver-related mortality and morbidity. Since the availability of direct-acting antivirals (DAA), HCV treatment has changed significantly. Current treatment strategies for different groups of patients as well as potential risks and caveats will be discussed in this review. Summary: Interferon-free (IFN-free) treatment not only shortens treatment duration, but also achieves high rates of viral clearance and is overall well tolerated. Genotype-restricted but also pangenotypic combinations are available. Usually two DAA of different drug classes are combined. For the majority of the patients, treatment duration ranges from 8 to 12 weeks. Liver and kidney function as well as prior treatment experience and potential drug-drug interactions influence substance choices and treatment duration. However, modern IFN-free treatment is not only safer, but also overall far more simplified and effective. Global HCV eradication might be an ambitious but not completely unrealistic goal to pursue. Key Messages: IFN-free antiviral treatment is safe and well tolerated. Patients can be treated almost independently of liver function or concomitant disease. Viral eradication is associated with reduced morbidity and mortality and better quality of life.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Gastroenterology, Hepatology and Endocrinology, Hannover Medical School, Hannover, Germany.
Zitieren
APA
Sandmann, L., Schulte, B., Manns, M. P., & Maasoumy, B. (2019). Treatment of Chronic Hepatitis C: Efficacy, Side Effects and Complications. Visceral Medicine, 35(3), 161-170. https://doi.org/10.1159/000500963
Vancouver
Sandmann L, Schulte B, Manns MP, Maasoumy B. Treatment of Chronic Hepatitis C: Efficacy, Side Effects and Complications. Visceral Medicine. 2019;35(3):161-170. doi:10.1159/000500963
BibTeX
@article{Sandmann2019,
author = {Sandmann, Lisa and Schulte, Benjamin and Manns, Michael P and Maasoumy, Benjamin},
title = {Treatment of Chronic Hepatitis C: Efficacy, Side Effects and Complications},
journal = {Visceral Medicine},
year = {2019},
volume = {35},
number = {3},
pages = {161--170},
doi = {10.1159/000500963}
}
EUVIMED